Sunday, March 6, 2011

Mesoblast Research Report

  • Southern Cross Equities has updated it's research on Mesoblast (MSB) with a Buy recommendation 
  • Report dated 03/03/2011
  • 12 month price target increased from $7 to $11. 
  • MSB last trade: $6.33 (04/03/2011)
  • Research link

No comments:

Post a Comment